Bioanalysis
Bioanalysis
Method Development for the Detection of Exicure’s AST-008 in Human Plasma
New issue of The Altascientist! Case studies on challenges encountered in ADA assays
A Lesson in Adaptability for the Determination of Rifampin
Selective Quantitation of 1,3-Propanediol in Dog Plasma Using Differential Ion Mobility Spectrometry
Patient Centricity — taking care of our most valuable asset!
.custom-column-left-text {
float: left;
width: 50%;
padding-right: 10px;
}
.custom-column-right-text {
float: right;
width: 45%;
text-align:center;
}
@media only screen and (max-width: 600px) {
.custom-column-left-text,
.custom-column-right-text,
.custom-column-flc-ebook-text {
float:none;
width:80%;
margin:0 auto;
}
}
“Patient centricity” is the process of designing a service or solution around the patient; more specifically, it is collectively defined as “Putting the patient fi
Will Biosimilars Replace Biologics?
.custom-column-left-text {
float: left;
width: 50%;
padding-right: 10px;
}
.custom-column-right-text {
float: right;
width: 45%;
text-align:center;
}
@media only screen and (max-width: 600px) {
.custom-column-left-text,
.custom-column-right-text,
.custom-column-flc-ebook-text {
float:none;
width:80%;
margin:0 auto;
}
}
Biologic drugs came on the market with the production of
Volumetric Absorptive Microsampling Combined With Impact-Assisted Extraction for Hematocrit Effect Free Assays
Development of an Affinity Capture - LC-MS/MS Assay for the Quantitation of Adalimumab in Human Plasma using BioBA Sample Preparation Kit
A Novel Strategy for the In-Process Stabilization of N-Oxide Metabolites in Hemolyzed Plasma Determined by LC-MS/MS
The Application of Research Grade MetabolitePilot™ Software for the Determination of Exenatide Catabolites Using HRAM With SWATH Acquisition